Showing 221 - 240 results of 901 for search '"Alzheimers"', query time: 0.08s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225

    Effect of Streblus asper Leaf Extract on Scopolamine-Induced Memory Deficits in Zebrafish: The Model of Alzheimer’s Disease by Kanathip Singsai, Natthanicha Ladpala, Natthan Dangja, Thanyaret Boonchuen, Niracha Jaikhamfu, Pirinyapat Fakthong

    Published 2021-01-01
    “…Our findings can be useful for further research to develop SA extract as a health product to ameliorate the symptoms of Alzheimer’s disease.…”
    Get full text
    Article
  6. 226
  7. 227

    Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial by Morgane Linard, Isabelle Garrigue, Bruno Vellas, Nicola Coley, Henrik Zetterberg, Kaj Blennow, Nicholas James Ashton, Pierre Payoux, Anne-Sophie Salabert, Jean-François Dartigues, Joachim Mazere, Sandrine Andrieu, Catherine Helmer

    Published 2025-01-01
    “…Here, we studied the association between HSV-1 and Alzheimer’s disease biomarkers in humans. Our sample included 182 participants at risk of cognitive decline from the Multidomain Alzheimer Preventive Trial who had HSV-1 plasma serology and an amyloid PET scan. …”
    Get full text
    Article
  8. 228

    A Comparative Interaction between Copper Ions with Alzheimer's β Amyloid Peptide and Human Serum Albumin by G. Rezaei Behbehani, L. Barzegar, M. Mohebbian, A. A. Saboury

    Published 2012-01-01
    “…The interaction of Cu2+ with the first 16 residues of the Alzheimer's amyliod β peptide, Aβ(1–16), and human serum albumin (HSA) were studied in vitro by isothermal titration calorimetry at pH 7.2 and 310 K in aqueous solution. …”
    Get full text
    Article
  9. 229
  10. 230
  11. 231

    Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer’s Disease: A comprehensive review by Hannah W. Haddad, Garett W. Malone, Nicholas J. Comardelle, Arielle E. Degueure, Salomon Poliwoda, Rachel J. Kaye, Kevin S. Murnane, Adam M Kaye, Alan D. Kaye

    Published 2022-07-01
    “…Alzheimer's disease (AD) is the most common form of dementia affecting millions of individuals, including family members who often take on the role of caregivers. …”
    Get full text
    Article
  12. 232

    Early Diagnosis of Alzheimer’s Disease Using Adaptive Neuro K-Means Clustering Technique by Karan Kumar, Shweta Agrawal, Isha Suwalka, Celestine Iwendi, Cresantus N. Biamba

    Published 2025-01-01
    “…Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, behavioral changes, and impaired self-care, often preceded by Mild Cognitive Impairment (MCI). …”
    Get full text
    Article
  13. 233
  14. 234
  15. 235

    Evaluation of Retinal Nerve Fiber Layer Thickness, Electroretinogram and Visual Evoked Potential in Patients with Alzheimer’s Disease by Qi Zhe Ngoo, Wan Hazabbah Wan Hitam, Asrenee Ab Razak

    Published 2019-01-01
    “…To study the retinal nerve fibre layer (RNFL) thickness and visual electrophysiology testing in patients with Alzheimer’s disease (AD). Methods. A cross-sectional, hospital-based study: 25 AD subjects and 25 controls were recruited. …”
    Get full text
    Article
  16. 236

    Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease by Nahed S. Alharthi, Fahad M. Aldakheel, Abdulkarim S. Binshaya

    Published 2022-01-01
    “…A critical factor in the cause and progression of Alzheimer’s disease (AD) is the growth of β-amyloid peptide (Aβ) in the brain. …”
    Get full text
    Article
  17. 237
  18. 238

    Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease by Ai-Ling Lin, Angela R. Laird, Peter T. Fox, Jia-Hong Gao

    Published 2012-01-01
    “…This paper discusses recent findings of the multimodal MRI in the context of surrogate biomarkers for identifying the risk for AD in normal cognitive (NC) adults, brain anatomical and functional alterations in amnestic mild cognitive impairment (aMCI), and Alzheimer's disease (AD) patients. Further developments of these techniques and the establishment of promising neuroimaging biomarkers will enhance our ability to diagnose aMCI and AD in their early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials.…”
    Get full text
    Article
  19. 239
  20. 240